350 articles related to "antiretroviral medicines"
Excerpt: "Doctors Without Borders/Médecins Sans Frontières (MSF) would like to submit the following written comments to the 2012 Special 301 Process. MSF also request...
Statements, Speeches, Letters – Last updated 10 February 2012
India has been called the ‘pharmacy of the developing world’ because it produces a large number of high-quality, affordable generic medicines. Thanks in large part to competition stemming...
Briefing – Last updated 09 February 2012
Unstructured treatment interruption of antiretroviral therapy in clinical practice: a systematic review
To characterize the frequency, reasons, risk factors, and consequences of unstructured anti-retroviral treatment interruptions. Seventy studies were included. The median proportion of patients interrupting...
In Medical Journals / Research Articles – Last updated 01 July 2011
Renal safety of a tenofovir-containing first line regimen: Experience from an antiretroviral cohort in rural Lesotho
Current guidelines contraindicate TDF use when creatinine clearance (CrCl) falls below 50 ml/min. We report prevalence of abnormal renal function at baseline and factors associated with abnormal renal...
In Medical Journals / Research Articles – Last updated 02 March 2011
Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa: A cohort analysis
Loss to follow-up (LTF) challenges the reporting of antiretroviral treatment (ART) programmes, since it encompasses patients alive but lost to programme and deaths misclassified as LTF. We describe...
In Medical Journals / Research Articles – Last updated 17 February 2011
Kinshasa, 25 January 2012 – Médecins Sans Frontières (MSF) is alarmed by the situation of HIV/AIDS patients in the Democratic Republic of Congo (DRC), the lack of priority given...
Press Release – Last updated 27 January 2012
The 2011 International Conference on HIV/AIDS and Sexually Transmitted Infections in Africa (ICASA) conference in Addis Ababa was an experience in contradictions. Presentations about promising new strategies...
Op-eds & Articles – Last updated 05 January 2012
Review of the safety, efficacy, and pharmacokinetics of elvitegravir with an emphasis on resource-limited settings
Integrase inhibitors represent an important new class of antiretroviral drugs. Elvitegravir, the second available integrase inhibitor to be submitted for regulatory approval appears to...
In Medical Journals / Research Articles – Last updated 11 January 2012
Resetting the agenda according to the needs: Antiretroviral sequencing or the best use of existing and promising pipeline HIV drugs.
Médecins Sans Frontières (MSF) with participation from Ensemble pour un Solidarité Thérapeutique Hospitaliere en Réseau (Esther) and Solidarité Thérapeutique...
Events & Presentations – Last updated 22 September 2011
Visceral leishmaniasis (VL), a protozoan disease transmitted by sandflies, is the second-biggest parasitic killer worldwide (after malaria). In Ethiopia, the host country for the ICASA 2011 conference,...
Op-eds & Articles – Last updated 03 January 2012